Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

Citation

(2010), "Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials", Clinical Governance: An International Journal, Vol. 15 No. 2. https://doi.org/10.1108/cgij.2010.24815bae.004

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 15, Issue 2

G. De Berardis, M. Sacco, G.F. Strippoli, F. Pellegrini, G. Graziano, G. Tognoni, A. Nicolucci,BMJ,2009,Vol. 339,b4531

This review concluded that a clear benefit of aspirin in the primary prevention of major cardiovascular events in people with diabetes was not proven. The pooled results should be viewed with caution; they were from studies with varied populations and aspirin regimens and might not represent the entire evidence base. Given the evidence presented, the conclusion seems to be appropriate.